Case Report

Uterus Wrapping: A Novel Concept in the Management of Uterine Atony during Cesarean Delivery

Table 1


CaseAge
(years)
ParityGestational age
(weeks)
Duration of cesarean section (min)Duration of uterus wrapping (min)Blood loss (mL)Preoperative hemoglobin
(g/L)
Post
operative hemoglobin
(g/L)
Medication

139140 5/79375200012597200 mcg misoprostol sublingually,
20 IU oxytocin i.v.,
500 mcg sulprostone i.v.,
1 g tranexamic acid i.v.,
1 g calcium i.v., and 1250 IU factor XIII i.v.

240138 4/75518110011290400 mcg misoprostol sublingually,
10 IU oxytocin i.v.,
500 mcg sulproston intramyometrially,
1000 mcg sulprostone i.v.,
1 g tranexamic acid i.v.,
1 g calcium i.v., and 1250 IU factor XIII i.v.

330142 1/75812800134121400 mcg misoprostol sublingually and
20 IU oxytocin i.v.